Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
The Pathophysiology of ITP and Novel Therapies
1:53:59
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
The Pathophysiology of ITP and Novel Therapies
1:53:59
|
Avatrombopag: a novel oral therapy for the treatment of ITP
1:53
|
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
1:54
|
Novel promising agents for the treatment of ITP
1:29
|
Idiopathic thrombocytopenic purpura - Pathology
6:08
|
Novel investigational drugs and promising therapies for immune thrombocytopenia
1:59
|
Shifting the treatment landscape of ITP: novel agents and future outlooks
1:32
|
Idiopathic Thrombocytopenic Purpura (ITP) -Pathophysiology, Clinical Features, Diagnosis & Treatment
8:19
|
Immunopathogenesis of ITP
14:10
|
Modern Management of ITP: Thinking Beyond the Conventional Therapies
33:06
|
ITP: novel treatments
1:06:04
|
The role and clinical use of TPO receptor agonists in the treatment of ITP
0:52
|
Immune Thrombocytopenia (ITP) | Idiopathic Thrombocytopenic Purpura [Updated 2024]
17:52
|
ITP: Second-Line Therapy
2:26
|
Immune Thrombocytopenia(ITP) in 8 minutes
8:47
|
ITP UK Stories Rhona
0:16
|
Avatrombopag, rilzabrutinib and COVID-19 updates in ITP
1:26
|
Session overview: improving treatment for patients with ITP
3:23
|
Thrombopoietin receptor agonists in ITP: current status and future outlooks
3:17
|
Low Platelet Levels and Advancements in Treatment
44:03
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
![Immune Thrombocytopenia (ITP) | Idiopathic Thrombocytopenic Purpura [Updated 2024]](https://i.ytimg.com/vi/sSSPXKugRkA/hqdefault.jpg)
